Verition Fund Management Portfolio holdings
AUM
$17.4B
1-Year Return
15.18%
This Quarter Return
+2.18%
1 Year Return
+15.18%
3 Year Return
+52.88%
5 Year Return
+61.62%
10 Year Return
+138.21%
AUM
$12.9B
AUM Growth
+$2.47B
(+24%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
23.59%
Holding
2,708
New
547
Increased
823
Reduced
679
Closed
374
Top Buys
| 1 |
Microsoft
MSFT
|
+$956M |
| 2 |
NVIDIA
NVDA
|
+$389M |
| 3 |
Amazon
AMZN
|
+$338M |
| 4 |
Apple
AAPL
|
+$154M |
| 5 |
DTE Energy
DTE
|
+$89.5M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$587M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$62.2M |
| 3 |
Xcel Energy
XEL
|
+$62M |
| 4 |
Consolidated Edison
ED
|
+$53.7M |
| 5 |
Salesforce
CRM
|
+$48.2M |
Sector Composition
| 1 | Technology | 24.41% |
| 2 | Consumer Discretionary | 13.97% |
| 3 | Financials | 11.08% |
| 4 | Industrials | 7.81% |
| 5 | Utilities | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Tenaris
TS
$18.8B
| $221K | ﹤0.01% |
7,229
-1,878
| -21% | -$57.3K |
|
1777
Amicus Therapeutics
FOLD
$2.47B
| $220K | ﹤0.01% |
22,199
+3,432
| +18% | +$34K |
|
1778
Chefs' Warehouse
CHEF
$2.69B
| $220K | ﹤0.01% |
5,628
-464
| -8% | -$18.1K |
|
1779
Ormat Technologies
ORA
$5.56B
| $219K | ﹤0.01% |
+3,056
| New | +$219K |
|
1780
CVB Financial
CVBF
$2.8B
| $219K | ﹤0.01% |
12,680
-19,844
| -61% | -$342K |
|
|
JVSA
1781
DELISTED
JV SPAC Acquisition Corp
JVSA
| $219K | ﹤0.01% |
+21,507
| New | +$219K |
|
1782
Atea Pharmaceuticals
AVIR
$262M
| $218K | ﹤0.01% |
+65,976
| New | +$218K |
|
1783
Triumph Financial, Inc.
TFIN
$1.35B
| $218K | ﹤0.01% |
+2,671
| New | +$218K |
|
1784
Akero Therapeutics
AKRO
$3.59B
| $217K | ﹤0.01% |
+9,256
| New | +$217K |
|
1785
Ameresco
AMRC
$1.44B
| $216K | ﹤0.01% |
+7,505
| New | +$216K |
|
1786
Qorvo
QRVO
$8.12B
| $215K | ﹤0.01% |
1,856
-1,467
| -44% | -$170K |
|
1787
Astronics
ATRO
$1.43B
| $215K | ﹤0.01% |
+10,744
| New | +$215K |
|
1788
Helios Technologies
HLIO
$1.85B
| $215K | ﹤0.01% |
4,505
-5,707
| -56% | -$273K |
|
1789
Heritage Financial
HFWA
$845M
| $215K | ﹤0.01% |
+11,929
| New | +$215K |
|
1790
Anterix
ATEX
$405M
| $215K | ﹤0.01% |
+5,426
| New | +$215K |
|
1791
Novo Nordisk
NVO
$241B
| $214K | ﹤0.01% |
1,502
-243
| -14% | -$34.7K |
|
|
DNB
1792
DELISTED
Dun & Bradstreet
DNB
| $214K | ﹤0.01% |
23,152
-211,894
| -90% | -$1.96M |
|
1793
REV Group
REVG
$3.12B
| $214K | ﹤0.01% |
8,603
-112,315
| -93% | -$2.8M |
|
1794
StoneX
SNEX
$5.14B
| $214K | ﹤0.01% |
+4,256
| New | +$214K |
|
1795
Walker & Dunlop
WD
$2.97B
| $214K | ﹤0.01% |
+2,175
| New | +$214K |
|
1796
10x Genomics
TXG
$1.63B
| $213K | ﹤0.01% |
+10,970
| New | +$213K |
|
1797
Matrix Service
MTRX
$360M
| $213K | ﹤0.01% |
+21,400
| New | +$213K |
|
1798
Brookfield Infrastructure
BIPC
$4.83B
| $212K | ﹤0.01% |
+6,284
| New | +$212K |
|
1799
Cohen & Steers
CNS
$3.66B
| $212K | ﹤0.01% |
+2,915
| New | +$212K |
|
1800
Adaptive Biotechnologies
ADPT
$2.05B
| $211K | ﹤0.01% |
58,357
+38,642
| +196% | +$140K |
|